Navigation Links
Campaign aims to simplify OTC drug labels

Americans buy about five billion over-the-counter drugs each year to treat routine health problems. The number has increased as more and more drugs have made the switch from prescription to over-the-counter status. But many Americans, particularly senior citizens, misuse over-the-counter drugs because the lettering is too small. Consumers have also complained that words like "indications," and "precautions" are too technical and confusing.//

The National Council on Patient Information and Education started a campaign with help from the Food and Drug Administration and other health organizations. Boldly printed drug labels and a new education campaign are the issues to be considered by consumer advocates and the government to make OTC drugs more user friendly.

The campaign, which will include television and radio spots, coincides with the government's changeover to new labels for these drugs. Most over-the-counter drugs manufactured after May will carry the new standardized "Drug Facts" label. The remainder of such drugs will comply by 2005. The FDA estimates that scores of medications are already carrying the new label.

"The purpose was to create simplicity," said Dr. Linda Katz, deputy director of FDA's division of OTC Products. She added that the new labels carry a larger print size to help consumers read the products. The use of bullets, spacing between lines and clearly marked sections are other changes aimed at improving the reading ability.
'"/>




Page: 1

Related medicine news :

1. Extensive Campaigning To Warn Against Children’s Growing Affinity To Fast Food In Britai
2. Chennai AIDS Campaign Highlights The Social Neglect Faced By Victims
3. Campaign Against Witchcraft In Orissa
4. Stroke Awareness Campaign Launched In Indian State
5. Campaigners Say No To Cannabis Reclassification
6. Australia To Start Campaign Against Obesity
7. Direct To Home: Television Provides Powerful Fillip to Smoking Cessation Campaigns.
8. See Me Campaign: Do Not Turn a Blind Eye and a Deaf Ear to Self-Harm
9. Substance Abuse Prevention Messages Better Received Among Teenagers in the Form of Media Campaigns and Curriculum
10. Famous Faces Join Campaign To Spread Awareness On Ovarian Cancer
11. Signature Campaign: Striking doctors take to the streets
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... April 28, 2017 , ... ... with the Home Care Association of America (HCAOA). This agreement allows HCAOA members ... services, as well as discounts on Accreditation University (AU) educational resources that help ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... 2017 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced ... its outlook as “stable.” At the same time, the ratings agency cautioned that the ... dip below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... 2017 Solentim, the developer of instrumentation ... of a major new product line called the ... VIPS has been developed for automatically seeding single ... part of the process to generate clonally-derived cell ... more reliable solution when compared to traditional single ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: